Header Logo

Connection

DAVID POPLACK to Killer Cells, Lymphokine-Activated

Back to Details
This is a "connection" page, showing publications DAVID POPLACK has written about Killer Cells, Lymphokine-Activated.
DAVID POPLACK
Connection Strength
0.006
Killer Cells, Lymphokine-Activated
  1. Serum CD25 levels during interleukin-2 therapy: dose dependence and correlations with clinical toxicity and lymphocyte surface sCD25 expression. J Immunother (1991). 1992 Feb; 11(2):111-8.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.